Drug Manufacturers - Specialty & Generic
Compare Stocks
5 / 10Stock Comparison
BGM vs USAS vs EXK vs PAAS vs AG
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial Materials
Other Precious Metals
Silver
Silver
BGM vs USAS vs EXK vs PAAS vs AG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Industrial Materials | Other Precious Metals | Silver | Silver |
| Market Cap | $2M | $2.03B | $2.99B | $24.36B | $10.55B |
| Revenue (TTM) | $25M | $109M | $330M | $4.02B | $1.27B |
| Net Income (TTM) | $-1M | $-61M | $-94M | $1.27B | $174M |
| Gross Margin | 16.4% | 3.3% | 9.3% | 43.8% | 35.5% |
| Operating Margin | -2.2% | -25.5% | -1.7% | 37.9% | 29.0% |
| Forward P/E | — | 27.7x | 14.3x | 12.4x | 20.9x |
| Total Debt | $0.00 | $24M | $120M | $935M | $314M |
| Cash & Equiv. | $10M | $20M | $106M | $1.21B | $792M |
BGM vs USAS vs EXK vs PAAS vs AG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 24 | May 26 | Return |
|---|---|---|---|
| BGM Group Ltd. (BGM) | 100 | 4.4 | -95.6% |
| Americas Gold and S… (USAS) | 100 | 1334.1 | +1234.1% |
| Endeavour Silver Co… (EXK) | 100 | 327.9 | +227.9% |
| Pan American Silver… (PAAS) | 100 | 292.6 | +192.6% |
| First Majestic Silv… (AG) | 100 | 391.1 | +291.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BGM vs USAS vs EXK vs PAAS vs AG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BGM is the #2 pick in this set and the best alternative if stability is your priority.
- Beta 0.67 vs USAS's 2.31
USAS ranks third and is worth considering specifically for momentum.
- +418.7% vs BGM's -97.4%
Among these 5 stocks, EXK doesn't own a clear edge in any measured category.
PAAS carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.74, yield 0.8%
- Rev growth 30.6%, EPS growth 7.4%, 3Y rev CAGR 35.1%
- 326.1% 10Y total return vs EXK's 182.7%
- Lower volatility, beta 0.74, Low D/E 13.4%, current ratio 2.69x
AG is the clearest fit if your priority is growth.
- 128.2% revenue growth vs BGM's -46.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 128.2% revenue growth vs BGM's -46.0% | |
| Value | Lower P/E (12.4x vs 20.9x), PEG 0.49 vs 0.80 | |
| Quality / Margins | 31.7% margin vs USAS's -56.2% | |
| Stability / Safety | Beta 0.67 vs USAS's 2.31 | |
| Dividends | 0.8% yield, 2-year raise streak, vs AG's 0.1%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +418.7% vs BGM's -97.4% | |
| Efficiency (ROA) | 14.0% ROA vs USAS's -26.1%, ROIC 15.7% vs -26.3% |
BGM vs USAS vs EXK vs PAAS vs AG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
BGM vs USAS vs EXK vs PAAS vs AG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PAAS leads in 3 of 6 categories
USAS leads 1 • BGM leads 0 • EXK leads 0 • AG leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
PAAS leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PAAS is the larger business by revenue, generating $4.0B annually — 160.1x BGM's $25M. PAAS is the more profitable business, keeping 31.7% of every revenue dollar as net income compared to USAS's -56.2%. On growth, AG holds the edge at +171.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $25M | $109M | $330M | $4.0B | $1.3B |
| EBITDAEarnings before interest/tax | — | -$7M | $49M | $2.0B | $636M |
| Net IncomeAfter-tax profit | — | -$61M | -$94M | $1.3B | $174M |
| Free Cash FlowCash after capex | — | -$52M | -$129M | $1.4B | $351M |
| Gross MarginGross profit ÷ Revenue | +16.4% | +3.3% | +9.3% | +43.8% | +35.5% |
| Operating MarginEBIT ÷ Revenue | -2.2% | -25.5% | -1.7% | +37.9% | +29.0% |
| Net MarginNet income ÷ Revenue | -5.7% | -56.2% | -28.4% | +31.7% | +13.7% |
| FCF MarginFCF ÷ Revenue | -13.5% | -47.7% | -39.1% | +34.0% | +27.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +45.6% | +154.0% | +49.2% | +171.8% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +55.3% | -97.5% | +134.8% | +4.8% |
Valuation Metrics
Evenly matched — BGM and PAAS each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 22.1x trailing earnings, PAAS trades at a 64% valuation discount to AG's 61.1x P/E. Adjusting for growth (PEG ratio), PAAS offers better value at 0.88x vs AG's 2.34x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2M | $2.0B | $3.0B | $24.4B | $10.6B |
| Enterprise ValueMkt cap + debt − cash | -$8M | $2.0B | $3.0B | $24.1B | $10.1B |
| Trailing P/EPrice ÷ TTM EPS | -1.43x | -15.19x | -78.08x | 22.15x | 61.06x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 27.70x | 14.34x | 12.39x | 20.94x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.88x | 2.34x |
| EV / EBITDAEnterprise value multiple | -11.51x | — | 76.02x | 14.00x | 15.82x |
| Price / SalesMarket cap ÷ Revenue | 0.08x | 20.24x | 13.72x | 6.61x | 8.25x |
| Price / BookPrice ÷ Book value/share | 0.05x | 12.65x | 5.07x | 3.16x | 3.27x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 22.52x | 30.01x |
Profitability & Efficiency
PAAS leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
PAAS delivers a 19.6% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-122 for USAS. AG carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to USAS's 0.45x. On the Piotroski fundamental quality scale (0–9), PAAS scores 7/9 vs USAS's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -3.3% | -122.1% | -18.4% | +19.6% | +5.9% |
| ROA (TTM)Return on assets | -2.8% | -26.1% | -9.2% | +14.0% | +4.1% |
| ROICReturn on invested capital | -1.2% | -26.3% | +1.5% | +15.7% | +13.1% |
| ROCEReturn on capital employed | -1.3% | -21.6% | +1.6% | +15.4% | +11.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 3 | 4 | 7 | 7 |
| Debt / EquityFinancial leverage | — | 0.45x | 0.25x | 0.13x | 0.10x |
| Net DebtTotal debt minus cash | -$10M | $4M | $14M | -$277M | -$478M |
| Cash & Equiv.Liquid assets | $10M | $20M | $106M | $1.2B | $792M |
| Total DebtShort + long-term debt | $0 | $24M | $120M | $935M | $314M |
| Interest CoverageEBIT ÷ Interest expense | -0.88x | -18.89x | -39.17x | 23.79x | 20.24x |
Total Returns (Dividends Reinvested)
USAS leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PAAS five years ago would be worth $17,139 today (with dividends reinvested), compared to $975 for BGM. Over the past 12 months, USAS leads with a +418.7% total return vs BGM's -97.4%. The 3-year compound annual growth rate (CAGR) favors USAS at 80.8% vs BGM's -62.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -92.0% | +24.9% | +12.5% | +13.6% | +33.1% |
| 1-Year ReturnPast 12 months | -97.4% | +418.7% | +193.4% | +137.5% | +241.7% |
| 3-Year ReturnCumulative with dividends | -94.8% | +490.7% | +144.0% | +229.9% | +212.9% |
| 5-Year ReturnCumulative with dividends | -90.3% | +35.7% | +61.1% | +71.4% | +31.0% |
| 10-Year ReturnCumulative with dividends | -90.3% | -5.1% | +182.7% | +326.1% | +128.5% |
| CAGR (3Y)Annualised 3-year return | -62.7% | +80.8% | +34.6% | +48.9% | +46.3% |
Risk & Volatility
Evenly matched — BGM and PAAS each lead in 1 of 2 comparable metrics.
Risk & Volatility
BGM is the less volatile stock with a 0.67 beta — it tends to amplify market swings less than USAS's 2.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PAAS currently trades 82.6% from its 52-week high vs BGM's 1.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.61x | 2.50x | 1.80x | 0.88x | 1.75x |
| 52-Week HighHighest price in past year | $17.17 | $10.50 | $15.15 | $69.99 | $32.03 |
| 52-Week LowLowest price in past year | $0.27 | $1.06 | $3.14 | $22.08 | $5.49 |
| % of 52W HighCurrent price vs 52-week peak | +1.7% | +60.8% | +67.0% | +82.6% | +66.7% |
| RSI (14)Momentum oscillator 0–100 | 31.4 | 56.3 | 47.6 | 54.8 | 52.9 |
| Avg Volume (50D)Average daily shares traded | 280K | 5.8M | 9.4M | 6.2M | 16.9M |
Analyst Outlook
PAAS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: USAS as "Buy", EXK as "Buy", PAAS as "Buy", AG as "Hold". Consensus price targets imply 52.8% upside for USAS (target: $10) vs 24.0% for AG (target: $27). PAAS is the only dividend payer here at 0.81% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $9.75 | $12.75 | $75.00 | $26.50 |
| # AnalystsCovering analysts | — | 4 | 14 | 24 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.8% | +0.1% |
| Dividend StreakConsecutive years of raises | 2 | — | 0 | 2 | 1 |
| Dividend / ShareAnnual DPS | — | — | — | $0.47 | $0.02 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +0.2% | +0.1% |
PAAS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). USAS leads in 1 (Total Returns). 2 tied.
BGM vs USAS vs EXK vs PAAS vs AG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BGM or USAS or EXK or PAAS or AG a better buy right now?
For growth investors, First Majestic Silver Corp.
(AG) is the stronger pick with 128. 2% revenue growth year-over-year, versus -46. 0% for BGM Group Ltd. (BGM). Pan American Silver Corp. (PAAS) offers the better valuation at 22. 1x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate Americas Gold and Silver Corporation (USAS) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BGM or USAS or EXK or PAAS or AG?
On trailing P/E, Pan American Silver Corp.
(PAAS) is the cheapest at 22. 1x versus First Majestic Silver Corp. at 61. 1x. On forward P/E, Pan American Silver Corp. is actually cheaper at 12. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Pan American Silver Corp. wins at 0. 49x versus First Majestic Silver Corp. 's 0. 80x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BGM or USAS or EXK or PAAS or AG?
Over the past 5 years, Pan American Silver Corp.
(PAAS) delivered a total return of +71. 4%, compared to -90. 3% for BGM Group Ltd. (BGM). Over 10 years, the gap is even starker: PAAS returned +335. 4% versus BGM's -89. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BGM or USAS or EXK or PAAS or AG?
By beta (market sensitivity over 5 years), BGM Group Ltd.
(BGM) is the lower-risk stock at 0. 61β versus Americas Gold and Silver Corporation's 2. 50β — meaning USAS is approximately 313% more volatile than BGM relative to the S&P 500. On balance sheet safety, First Majestic Silver Corp. (AG) carries a lower debt/equity ratio of 10% versus 45% for Americas Gold and Silver Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — BGM or USAS or EXK or PAAS or AG?
By revenue growth (latest reported year), First Majestic Silver Corp.
(AG) is pulling ahead at 128. 2% versus -46. 0% for BGM Group Ltd. (BGM). On earnings-per-share growth, the picture is similar: Pan American Silver Corp. grew EPS 741. 9% year-over-year, compared to -519. 4% for Endeavour Silver Corp.. Over a 3-year CAGR, PAAS leads at 35. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BGM or USAS or EXK or PAAS or AG?
Pan American Silver Corp.
(PAAS) is the more profitable company, earning 27. 0% net margin versus -44. 9% for Americas Gold and Silver Corporation — meaning it keeps 27. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PAAS leads at 32. 3% versus -26. 2% for USAS. At the gross margin level — before operating expenses — PAAS leads at 37. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BGM or USAS or EXK or PAAS or AG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Pan American Silver Corp. (PAAS) is the more undervalued stock at a PEG of 0. 49x versus First Majestic Silver Corp. 's 0. 80x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Pan American Silver Corp. (PAAS) trades at 12. 4x forward P/E versus 27. 7x for Americas Gold and Silver Corporation — 15. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for USAS: 52. 8% to $9. 75.
08Which pays a better dividend — BGM or USAS or EXK or PAAS or AG?
In this comparison, PAAS (0.
8% yield) pays a dividend. BGM, USAS, EXK, AG do not pay a meaningful dividend and should not be held primarily for income.
09Is BGM or USAS or EXK or PAAS or AG better for a retirement portfolio?
For long-horizon retirement investors, Pan American Silver Corp.
(PAAS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 88), 0. 8% yield, +335. 4% 10Y return). Americas Gold and Silver Corporation (USAS) carries a higher beta of 2. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PAAS: +335. 4%, USAS: -1. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BGM and USAS and EXK and PAAS and AG?
These companies operate in different sectors (BGM (Healthcare) and USAS (Basic Materials) and EXK (Basic Materials) and PAAS (Basic Materials) and AG (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BGM is a small-cap quality compounder stock; USAS is a small-cap quality compounder stock; EXK is a small-cap quality compounder stock; PAAS is a mid-cap high-growth stock; AG is a mid-cap high-growth stock. PAAS pays a dividend while BGM, USAS, EXK, AG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.